Evidence map›Paper›PMID 36238587›Full record

ArticleFrontiers in microbiology2022

Comparison of inhibitory effects and mechanisms of lactonic sophorolipid on different pathogenic bacteria.

Xiao-Jing Ma, Tong Wang, Hui-Min Zhang, Jun-Qian Shao, Mei Jiang, Huai Wang, Hui-Xia Zhu, Dong Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Lactonic sophorolipids byRSC advances · 2025
    Article
  6. Article
  7. Harnessing dual applications of a novel ascomycetes yeast,Frontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiao-Jing MaSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Tong WangSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Hui-Min ZhangSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Jun-Qian ShaoSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Mei JiangSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Huai WangSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Hui-Xia ZhuSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
Dong ZhouDepartment of Pediatrics, Qilu Hospital of Shandong University, Jinan, China.
Hefei University of Technology · CNQilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crude sophorolipids (SLs) have been proven to perform varying degrees of inhibitory effects on different pathogenic bacteria. However, systematic comparative studies of pure lactonic sophorolipid (LSL) among different types of bacteria are few. In this study, the antibacterial effects and mechanisms of LSL on pathogenic bacteria of

Indexed as

antibacterial effectantibacterial mechanismlactonic sophorolipidpathogenic bacteriaPseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID36238587
PMCPMC9552708
OpenAlexW4297383511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.